Ancom Nylex earnings uplift likely to ease ahead

TheStar Thu, Jul 23, 2026 12:00am - 1 month View Original


HLIB Research highlighted that MSMA (monosodium methanearsonate) orders for Brazil’s soybean market have started materialising following its label approval in March 2026.

PETALING JAYA: Ancom Nylex Bhd’s industrial chemicals segment is experiencing a Brent-driven uplift, which is likely to moderate from the second quarter of the financial year 2027 (2Q27) should crude oil prices ease amid any de-escalation in the Iran war, says Hong Leong Investment Bank (HLIB) Research.

In its 4Q ended May 31, 2026, the company saw its core net profit rise quarter-on-quarter by 12.5% to RM25.9mil and its revenue increase by 36.5% to RM608.88mil.

The research house said Ancom Nylex’s strong performance was driven by significant growth in the industrial chemicals segment of 82.5%, underpinned by higher average selling prices following the rise in Brent oil prices, in addition to a modest 5.5% improvement in its logistics segment.

“This was partly offset by weaker agrichem revenue (minus 18.4%), mainly due to a weaker US dollar versus ringgit.”

...

Full Article on TheStar

The content is a snapshot from Publisher. Refer to the original content for accurate info. Contact us for any changes.






Related Stocks

ANCOMNY 0.875

Comments

Login to comment.